The basic group planning of humans completed the full-scale genetic planning of the human body in 2003. Of course, the high time and economic cost in the middle of the first generation of genetic testing took 12 years, and the cost was billions. However, after experiencing the experience of the first session, the second-generation test has not only reduced the cost, but also shortened the time by a half year. In the following years, China’s genetic research technology has been continuously transmitting a major breakthrough in the United States. The White House released the "New Strategy for American Innovation", which clearly identified China's gene therapy and precision medicine as an important strategy in the overseas medical field. The precise medical plan for China's basic treatment was also launched during the year, and it also opened a huge commercial space for basic medical cooperation at home and abroad. .
- According to media reports, the recent cooperation between Chinese and American researchers in the field of gene sequencing has once again made important breakthroughs. In response to the reality that the hardware error rate of the third-generation gene sequencer is as high as 15%-40%, the team has jointly developed a new algorithm, and the software with the new algorithm has a result error rate of less than 0.5%, and also saves Sequencing time and memory up to 80%. Intel has launched the Intel Precision Medical Partner Program, which is expected to complete a series of precise medical procedures such as gene sequencing-medical analysis-medical solutions within 24 hours by 2020.
The rise of genetic testing technology has greatly promoted the rapid development of precision medicine. In 2015, the global precision medical market was nearly 60 billion US dollars. According to the agency's forecast, the scale of the global precision medical market will continue to grow rapidly in the next five years. The growth rate will reach 15% during the period of 2015-2020, which is 3-4 times that of the pharmaceutical industry. A major breakthrough in gene sequencing is expected to further promote the outbreak of precision medicine.
Author's point of view: The third generation of gene sequencing research has achieved a perfect breakthrough in the past two years, the ultimate goal is that human whole sequence gene sequencing is only 24 hours, 1000 dollars, then a single drop of blood can be sequenced, with this The error rate of the next three generations of further sequencing technology is 15% to 40%. The Chinese Academy of Sciences and the US basic testing field formed a team to re-develop, and finally the results calculated by Sparc were less than 0.5%. This is not only a comprehensive embarrassment of the three generations of technology, but also a major honor for the domestic genetic research and development team. The life cycle also determines the health of human beings. Basic mutations can also be directly used by precision instruments, and individualized professional treatment is carried out on drugs. Under the background, the market is full of confidence in gene therapy-related companies. Listed companies are laid out in the field of gene therapy.
Agaricus Blazei Murill,Agaricus Blazei Murill Mushroom,Agaricus Blazei,Dried Agaricus
Guangyun Agricultural Biotechnology (Jiangsu) Co., Ltd , https://www.7-mushrooms.com